Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
Aged
Alzheimer Disease
/ complications
Amyloid beta-Peptides
/ cerebrospinal fluid
Apathy
Biomarkers
/ cerebrospinal fluid
Caregivers
Executive Function
Female
Humans
Hydrocephalus, Normal Pressure
/ complications
Male
Middle Aged
Neuropsychological Tests
Peptide Fragments
/ cerebrospinal fluid
Positron-Emission Tomography
tau Proteins
/ cerebrospinal fluid
Amyloid
Apathy
Cerebrospinal fluid
Cognition
Dementia
Executive function
Hydrocephalus
Journal
Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
21
5
2020
medline:
15
10
2021
entrez:
21
5
2020
Statut:
ppublish
Résumé
Cognitive impairment and apathy are well-documented features of idiopathic normal pressure hydrocephalus (iNPH). However, research examining other neuropsychiatric manifestations of iNPH is scant, and it is unknown whether the neuropsychiatric presentation differs for iNPH patients with comorbid Alzheimer's disease (AD) versus iNPH without AD. This study aims to advance our understanding of neuropsychiatric syndromes associated with iNPH. Fifty patients from Butler Hospital's Normal Pressure Hydrocephalus Clinic met inclusion criteria. Caregiver ratings on the Frontal Systems Behavior Scale (FrSBe) were examined to appraise changes in apathy, executive dysfunction, and disinhibition. Patients also completed cognitive tests of global cognition, psychomotor speed, and executive functioning. AD biomarker status was determined by either amyloid-beta (Aβ) positron emission tomography (PET) imaging or cerebrospinal fluid (CSF) total tau to Aβ-42 ratio. Results revealed clinically significant elevations on the FrSBe's apathy and executive dysfunction scales and modest correlations among these scales and cognitive measures. Of the 44 patients with available neuroimaging or CSF draw data, 14 presented with comorbid AD. Relative to the iNPH-only group, the iNPH + AD group showed a larger increase from pre-illness to current informant ratings on the executive dysfunction scale, but not the apathy or disinhibition scales. These results replicate and extend prior research by identifying apathy and executive dysfunction as prominent neuropsychiatric symptoms of iNPH and suggest comorbid AD exacerbates dysexecutive behaviors. Future research is warranted to examine the effects of comorbid AD pathology in response to shunt surgery for iNPH, neuropsychiatric symptom changes, and resultant caregiver burden.
Identifiants
pubmed: 32430087
pii: S1355617720000387
doi: 10.1017/S1355617720000387
pmc: PMC7554119
mid: NIHMS1578596
doi:
Substances chimiques
Amyloid beta-Peptides
0
Biomarkers
0
Peptide Fragments
0
tau Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
883-893Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM115677
Pays : United States
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Neurol Sci. 2018 Apr 15;387:21-26
pubmed: 29571865
Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):222-8
pubmed: 12611752
PLoS One. 2017 Aug 17;12(8):e0181624
pubmed: 28817574
Behav Neurol. 2009;21(3):165-74
pubmed: 19996513
Alzheimers Dement. 2014 Nov;10(6):808-17
pubmed: 25150736
Acta Neurol Scand. 2007 Nov;116(5):328-32
pubmed: 17922726
Gerontol Geriatr Med. 2016 Apr 20;2:2333721416643702
pubmed: 28138494
Rev Neurol (Paris). 2013 Oct;169(10):695-708
pubmed: 24011643
J Psychosom Res. 2002 Aug;53(2):647-54
pubmed: 12169339
Am J Geriatr Psychiatry. 2003 Nov-Dec;11(6):683-6
pubmed: 14609810
Funct Neurol. 2016 Jul-Sep;31(3):143-7
pubmed: 27678207
Arch Neurol. 2001 Mar;58(3):373-9
pubmed: 11255440
Neurology. 2014 Oct 21;83(17):1573-5
pubmed: 25332445
Int J Psychophysiol. 2017 Sep;119:127-131
pubmed: 27965058
J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):157-61
pubmed: 17012342
N Engl J Med. 1965 Jul 15;273:117-26
pubmed: 14303656
Int J Geriatr Psychiatry. 2018 May;33(5):735-742
pubmed: 29292530
Dement Geriatr Cogn Disord. 2006;21(2):113-9
pubmed: 16374006
Alzheimers Dement. 2007 Jul;3(3):200-3
pubmed: 19595938
J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):296-302
pubmed: 12154154
Clin Neuropsychol. 2016;30(1):95-106
pubmed: 26789092
JAMA. 2011 Jan 19;305(3):275-83
pubmed: 21245183
Neurosurgery. 2011 Feb;68(2):416-9
pubmed: 21135747
J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):778-81
pubmed: 10811706
Br J Neurosurg. 2016;30(1):38-42
pubmed: 25968325
J Int Neuropsychol Soc. 2011 Sep;17(5):759-65
pubmed: 21729406
Int Psychogeriatr. 2013 Aug;25(8):1345-55
pubmed: 23651733
J Neurol Sci. 2016 Oct 15;369:236-241
pubmed: 27653897
Am J Geriatr Psychiatry. 2013 Jan;21(1):14-25
pubmed: 23290199
Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):214-21
pubmed: 12611751
Am J Psychiatry. 1990 Jan;147(1):22-30
pubmed: 2403472
Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):579-99
pubmed: 27042909
J Neurol Sci. 2016 Feb 15;361:206-12
pubmed: 26810545
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Am J Geriatr Psychiatry. 2001 Winter;9(1):41-8
pubmed: 11156751
J Neurol. 2018 Jan;265(1):63-73
pubmed: 29128930
Clin Neurol Neurosurg. 2008 Apr;110(4):369-75
pubmed: 18262344
Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):248-53
pubmed: 12468899
J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9
pubmed: 11001602
Acta Neurol Scand. 2001 Dec;104(6):325-42
pubmed: 11903086
J Nutr Health Aging. 2015 Mar;19(3):365-72
pubmed: 25732223
J Cereb Blood Flow Metab. 2007 Apr;27(4):803-10
pubmed: 16926840
Cogn Behav Neurol. 2003 Mar;16(1):54-67
pubmed: 14765002
Neurosurgery. 2016 Feb;78(2):161-8
pubmed: 26528670